The Endocannabinoid System May Provide Sex-Specific Treatment Methods for Stress

In Summary

A recent study has found the receptors in the endocannabinoid system may behave differently in men and women during times of stress. This sex-specific mechanism may provide novel treatment methods for patients suffering from stress and anxiety disorders. Previous studies have shown how the endocannabinoid system and stress, ruled by norepinephrine, interact with each other, but this new information depicting the activity of the endocannabinoid during the dysregulation of norepinephrine is likely to provide evidence for sex-specific treatment of psychiatric disorders. 

This study brings to light the larger issue of specific treatment methods for men and women. Clinical trials often begin by distributing the drug therapy to a small number of healthy male patients, which helps researchers determine dosing, toxicity, and the overall effect. Medications are rarely dosed based on sex despite numerous studies discovering sex-specific mechanisms in the brain. The research highlighted in this post is one of many that highlights the need for specific medications.

View this review (yellow link) or download:

This paper is also stored HERE inside the CED Foundation Archive

To explore related information, click the keywords below: